NIH #F32CA236126
INVESTIGATING THE MOLECULAR BASIS OF OLAPARIB RESISTANCE IN BRCA2-DEFICIENT PROSTATE CANCER
- Amount
- <$100K
- Period
- 2018-12-01 → 2021-11-30
- PIs
- 1
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Kyrie Pappas
Full Professor(heuristic)
Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index8
i10-index7
Publications31
Citations592
Grants
2 total · 0 active
NIH #F31CA183268
Molecular mechanisms of transcriptional repression of PTEN in human breast cancer
- Amount
- <$100K
- Period
- 2014-03-01 → 2017-02-28
- PIs
- 1
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: BRCA2 reversion mutation–independent resistance to PARP inhibition through impaired DNA prereplication complex function (Proceedings of the National Academy of Sciences)2025-06-03
- New preprint: BRCA2 reversion mutation-independent resistance to PARP inhibition in prostate cancer through loss of function perturbations in the DNA pre-replication complex2025-04-24
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-09
Data may not be current
Find elsewhere
ORCID: 0000-0002-1828-246X